Clinical Trials Logo

Clinical Trial Summary

Amphetamine-type stimulants (ATSs) have become the most important medical issue as well as the social problem. Compared with traditional drugs, ATS are highly neurotoxin and can induce cognitive deficit and psychotic symptoms. Due to lack of efficient medical treatment, psychotherapy and behavioral interventions are the main treatment strategies so far. Mindful-based relapse prevention (MBRP) which combined mindfulness with relapse prevention skills, as a novel intervention, has been widely used in prevent craving and relapse among addictions. While the current research of MBRP mechanism focus on emotion regulation circuit, and there was no study to explore the impulsive circuit, which is the important factor that induce the addiction and relapse. However, there was no report about the influence of MBRP on Prefrontal-striatal circuits. Based on the previous results, the proposed study will focus on evaluating the mechanism of MBRP on prefrontal-striatal circuits, neuropsychological tests and functional MRI will be used to investigate the neurobiological mechanism of MBRP on prefrontal-striatal circuits and related impulsive behaviors.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03748875
Study type Interventional
Source Shanghai Mental Health Center
Contact Jiang DU, Doctor
Phone 021-64906315
Email dujiangdou@163.com
Status Not yet recruiting
Phase N/A
Start date May 1, 2020
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT05916989 - Stimulant Use and Methylation in HIV
Recruiting NCT04927143 - Encouraging Abstinence Behavior in a Drug Epidemic Phase 2
Completed NCT04449055 - Pilot TMS for Methamphetamine Use Disorder N/A
Completed NCT06288997 - tACS Intervention for Methamphetamine Addiction N/A
Active, not recruiting NCT05162391 - Inflammation in Methamphetamine and STIs (IMSTI) N/A
Completed NCT03336866 - Study of Antibody for Methamphetamine Outpatient Therapy Phase 1/Phase 2
Not yet recruiting NCT06233799 - Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder Phase 3
Recruiting NCT03341078 - Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users Phase 2
Active, not recruiting NCT03910608 - Paired Associative Stimulation in Methamphetamine Addiction N/A
Terminated NCT05283304 - Monthly Injectable BUP for MA Use Disorder (MURB) Trial Phase 2
Completed NCT04563962 - Contingency Management for PrEP Adherence and/or Methamphetamine Use N/A
Not yet recruiting NCT05334914 - ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals N/A
Terminated NCT05034874 - Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 Phase 2
Recruiting NCT06434818 - Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders Phase 2
Recruiting NCT06027814 - MHealth Incentivized Adherence Plus Patient Navigation N/A
Completed NCT04544124 - Delivering Contingency Management in Outpatient Addiction Treatment N/A
Completed NCT01217970 - Safety Interaction Trial Ibudilast and Methamphetamine Phase 1
Completed NCT03825536 - Effect of Methamphetamine on Residual Latent HIV Disease Study Phase 4
Recruiting NCT03470480 - rTMS for Craving in Methamphetamine Use Disorder N/A
Recruiting NCT05128071 - PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT) Early Phase 1